Use cases in genAI fall into 2 buckets. 1) CROs & biopharma companies looking to remove friction, create the first version of that document, or ask questions of huge data. Then there are the builders. All they want are APIs w/out the worry of plumbing & orchestration Ryght #AI

The #1 driver of new customers for Ryght is abstraction of complexity so that #ai builders can focus on solving the problem, not managing complexity & timing of the back end. We abstract prompt chaining, picking LLMs, routing to APIs, RAG, embedding so AI @ scale just works.

Check out my latest article: Ryght At The Forefront: The GenAI Enterprise Unlock (and wooly mammoths) linkedin.com/pulse/ryght-fo… via LinkedIn

Great to join you chadi nabhan MD, MBA, FACP

Thx Hugging Face 🤗 for including @Ryght in your latest blog! Our strategic partnership and integration with HF's #ML services underscores our commitment to delivering cutting-edge solutions in #healthcare and #lifesciences. Sign up for Ryght #Preview today (link in comments)👇

Yesterday RYGHT launched our Preview product and the results were good. Onward and upward

Exciting News! We're thrilled to announce a new partnership with nmible to support better #clinicaltrials. nmible will incorporate #Ryght's advanced #GenAI into its platform. Read the full press release here: hubs.li/Q02vt9X60 #CRO #Biotech #Pharma

We're thrilled to announce a strategic partnership with the Uni of Adelaide - a top 100 global university. This collaboration will leverage Ryght's #GenAI platform to drive impactful #research and develop innovative #AI solutions nationwide. PR 👉hubs.li/Q02zpWsr0

Big news! 🎉 Ryght joins the #CancerX Program to drive innovation in #CancerResearch! 🚀 We're proud to be part of this initiative to accelerate AI-driven advancements in clinical trials. Learn more: hubs.li/Q02GXDwq0 #GenAI #HealthcareInnovation #CancerMoonshot

Appreciative that SmartCompany chose to include me in their article - bring on the Paris 2024 Olympics !!

Good timing! 😂 x.com/salgadinhomusi…

Big day as we announce the the great Tarek Sherif as an investor and advisor to Ryght . Tarek has one of those amazing stories, having co-founded Medidata Solutions from the dot com era, not having been able to raise VC, bootstrapping an IPO and exiting to Dassault Systèmes for $5.8B

Ouch

Our Founder, Simon Arkell, joined Bradley Bostic today on the Boombostic Health podcast. They discuss how Ryght AI is at the forefront of innovation by utilizing generative AI in clinical trials. 🎧Listen here -hubs.li/Q02XPVbk0 #AI #healthcare #podcast #innovation

Great to be invited to do the Boombostic Health Podcast with Brad Bostic. podcasts.apple.com/us/podcast/boo…

$1M fine for any company advertising on TV with the sound of a doorbell.

Excited to share the close of our second fund, “V2”, at $55.75 million. Thank you to all the founders that we’ve had the privilege to work with and our LPs for their support! Upwards and onwards 🚀

AI Agents will be the biggest shift to enterprise software business models that we've ever seen. The typical business model of enterprise software has generally been that one user on the system equals one licensed seat. This model is obviously logical in a world where most

Delighted to keep adding major academic medical centers to the Ryght Research Network. Clinical trial sponsors and CROs now access tens of thousands of sites around the world, including major partners like this with #AgenticAI driving real time selection and fast activation.

Super excited to close a seed round in this environment for Ryght. We have created an AI digital twin of every clinical trial site in the world and changing the game for sponsors and CROs needing the best sites for their trial fast. We also automate documents and research.